potential sampling error on biopsy, perhaps due to an inability to visualize the involved area in older women due to an upward migration of the TZ.
be associated with cervical squamous intraepithelial lesions (SIL) [1] . Several studies have reported a 22-46% incidence of HPV infection in premenopausal women [2, 3] . The incidence of SIL is approximately 3 times greater in premenopausal women in whom HPV has been detected versus those who are HPV-negative [4] . The incidence of HPV infection is significantly higher in premenopausal than in postmenopausal women (1%) [5] . As part of our cytopathology quality assurance program, and as mandated by the College of American Pathologists for laboratory accreditation, we routinely review Pap smears and biopsies that lack diagnostic correlation. We have observed that the lack of correlation seems to be highest in postmenopausal women (personal observation) when compared to premenopausal women. The primary objective of our study is to compare the actual cytohistologic correlation between premenopausal and postmenopausal women, the HPV status of the 2 groups and the correlation with cytohistologic findings.
Material and Methods
This study was initiated after obtaining institutional review board approval. A total of 68,738 ThinPrep Pap smears were done at our institutional from January 2011 to December 2011. The Pap smears were prepared by using a liquid-based method following the manufacturer's guidelines (ThinPrep 3,000; Hologic, Inc., Marlborough, Mass., USA) and stained utilizing the standard Papanicolaou technique. Pap smears with subsequent colposcopic directed biopsy performed within 3 months of obtaining the Pap smears were included in the study. All of the Pap smears were screened by cytotechnologists certified by the American Society of Cytopathology, and abnormal cases were reviewed by one of four Board-certified cytopathologists. A total of 865 cases had a corresponding colposcopic biopsy performed within 3 months of obtaining the Pap smears. Of these 865, 787 were premenopausal (29.33 ± 8.5, mean age ± SD) and the remaining 78 (29.33 ± 8.5, mean age ± SD) were postmenopausal. By convention, the Pap smears were evaluated by treating the corresponding histologic diagnosis as the gold standard. Based on the corresponding histology, Pap smears were categorized as true positive (TP), false positive (FP), false negative (FN) or true negative (TN) with respect to the corresponding biopsy. For the purposes of the study, only Pap smears with a diagnosis of normal/reactive, low-grade or highgrade squamous intraepithelial lesion (LSIL or HSIL) and adenocarcinoma (ADC) were included, and patients who underwent colposcopic biopsy following an equivocal diagnosis (atypical squamous cells of undetermined significance or atypical squamous cells -cannot exclude HSIL or atypical glandular cells) were excluded. Of the 787 premenopausal women and 78 postmenopausal women, 387 and 40 cases, respectively, were selected based on our inclusion criteria. The cytologic diagnoses were rendered by one of the four Board-certified cytopathologists at our institution. All cytohistologic discrepancies were reviewed by the director of the cytopathology laboratory (P.F.M.) in order to exclude errors in interpretation. We also collected the results of testing for high-risk HPV DNA, by Digene Hybrid Capture II (Qiagen, Gaithersburg, Md., USA) when available. Statistical analysis was performed by using the McNemar test for paired data. All data were analyzed using SPSS v. 19.0 and p ≤ 0.05 was considered to indicate statistical significance.
Results
Of the 387 premenopausal women, 215 (55.5%) were TP, 130 (33.6%) were classified as FP, while 7 (1.8%) and 35 (9%) were characterized as FN and TN, respectively ( table 1 ). There was a statistically significant correlation among premenopausal women (p < 0.0001) and postmenopausal women (p < 0.0001). We calculated that, in premenopausal women, the positive predictive value (PPV) for the ThinPrep Pap smear was 62% compared to 38% in postmenopausal women, while the sensitivity was 97 and 87%, respectively. Furthermore, we observed that 17% (22/130) of the FP premenopausal women lacked a transformation zone (TZ) on the following colposcopic directed biopsies. In contrast, we found 21 (52.5%, n = 40) FP Pap smears in postmenopausal women; nearly half (47.6%) of these women lacked a TZ on the subsequent biopsies. Interestingly, most of the cases with no TZ, particularly in postmenopausal women, had biopsies from multiple sites on the cervix ( table 2 , 3 ) . We observed 7 (1.8%) FN cases in premenopausal women, all but 1 exhibiting cervical intraepithelial neoplasia grade 1 (CIN1) on biopsy. In contrast, 2 (5%) FN cases were found in postmenopausal women, 1 was found to have CIN1 on corresponding biopsy, while the other was diagnosed with CIN3 ( table 4 ) .
Of the 215 TP premenopausal women, the cytologic diagnosis was LSIL in 158 (73.5%) and HSIL in 57 (26.5%). Of the 158 premenopausal women with TP LSIL cytology, the majority, 125 (79%), had a biopsy diagnosis of CIN1 while 33 (21%) had a biopsy diagnosis of CIN2/3. Of the 57 premenopausal women with TP HSIL cytology, 45 (79%) had a corresponding biopsy diagnosis of CIN2/3 while 12 (21%) had a biopsy diagnosis of CIN1. Of the 13 TP postmenopausal women, the cytologic diagnosis was LSIL in 6 (46%), HSIL in 4 (31%) and ADC in 3 (23%) cases. Of the 13 postmenopausal women with TP LSIL, the majority (83.3%) had a biopsy diagnosis of CIN1, except for 1 (16.7%). However, of the 7 postmenopausal women with TP HSIL/ ADC cytology, 6 (85.7%) had a biopsy diagnosis of CIN2/3 or ADC ( table 5 ) .
Overall, 35 premenopausal women and 4 postmenopausal women were categorized as TN. The comprehensive features of TN are summarized in table 6 .
Of the patients included in the study, high-risk HPV testing by Digene Hybrid Capture II was performed on 90 premenopausal and 11 postmenopausal women. Of the 90 premenopausal women who underwent high-risk HPV testing, 52 were patients with TP cytology. Of these, 40 (77%) were positive for high-risk HPV and 12 (23%) were negative. Of the postmenopausal women with TP cytology, 3 were tested for high-risk HPV: 2 (66.7%) tested positive and 1 (33.3%) was negative ( table 5 ) . Interestingly, with respect to high-risk HPV testing in patients having both Pap smear and biopsies performed, we found the Pap smear diagnoses were a better predictor of positive high-risk HPV in premenopausal versus postmenopausal women (sensitivity = 97.0 vs. 87.5%) than the respective colposcopic biopsies (Sensitivity = 61.0 vs. 37.5%), whereas the PPVs were similar (75 vs. 77.3% in Pap smears and 77.8 vs. 75% in colposcopic biopsies, respectively) ( table 7 ). 
Discussion
Pap smear is a valuable noninvasive test for the screening of cervical dysplasia and cancer. For quality assurance purposes, it is necessary to perform cytohistologic correlation. According to the American Society for Colposcopy and Cervical Pathology guidelines, the preferred screening method for women aged 30-65 years is HPV and cytology 'cotesting' every 5 years, while cytology alone every 3 years is recommended for women younger than 30 years of age [6] . The incidence of finding dysplasia decreases with age [6, 7] . The cervical mucosa undergoes morphologic variations with age, and practising cytopathologists must be keenly aware of these differences in order to make accurate diagnoses [8] . Atrophic changes in postmenopausal patients due to lack of estrogenic stimulation can pose diagnostic challenges because they may simulate high-grade dysplasia morphologically [9] . Ejersbo et al. [10] suggested the use of Ki-67 in difficult cases to differentiate atrophic atypia from high-grade dysplasia. Ki-67 is a proliferation marker which can be utilized due to differences in the proliferation index between atrophic atypia and high-grade dysplasia. However, performing immunohistochemical staining on cytologic smears has its own challenges, and we do not use Ki-67 staining as an adjunct for the interpretation of Pap smears. Moore et al.
[11] observed a 41% incidence of high-grade CIN in subsequent biopsies in postmenopausal women with low-grade or atypical squamous cells of undetermined significance cytology, versus a 29% incidence in premenopausal women. In our study, we observed that postmenopausal women who had Pap smears with SIL (of any grade) had a 32.5% incidence (TP 13, n = 40) of dysplasia in the subsequent biopsies versus a 55.5% incidence (TP 215, n = 387) in the premenopausal cohort (PPV = 38 vs. 62%, respectively). Abali et al. [12] reported a FP rate for Pap smears of 22.68% in women with a mean age of 45 years (PPV for LSIL = 38% vs. HSIL = 62%). We did not distinguish between premenopausal and postmenopausal women when analyzing the results. We observed a FP rate for Pap smears relative to the subsequent colposcopic biopsies of 33.6% in premenopausal women versus 52.5% in postmenopausal women. Our increased FP rate may be due to overaggressive interpretations of Pap smears in our institution or differences in the skill of the colposcopists in identifying and sampling cervical epithelial lesions. Remarkably, of the 52.5% FP postmenopausal women, nearly half (47.6%) lacked a TZ in the colposcopic directed biopsies that followed. Most of these biopsies were from the multiple sites on the cervix. We suggest that optimal sampling should include the cervical TZ. Several studies have confirmed the fact that the TZ or squamocolumnar junction is the point of origin for HPV and other precancerous lesions [13] [14] [15] . Therefore, biopsies lacking the TZ may not be as reliable at sampling the actual dysplastic lesion. Our data certainly support this contention. Interestingly, 83.3% of our FP postmenopausal cases with an absent TZ in the corresponding biopsies were positive for HPV DNA. This is especially noteworthy because the incidence of HPV decreases with age, and in postmenopausal women the incidence of HPV infection drops significantly compared to in premenopausal women [16] . The recommendation for HPV testing is variable in each age group [6] . Ferenczy et al. [5] demonstrated a 1% incidence of HPV infection in postmenopausal women. In contrast, the incidence of HPV infection in women in their mid-20s is significantly higher, ranging between 39.2 and 44.8% [17, 18] Jackson et al. [19] suggested combining the use of p16 and Ki-67 immunohistochemistry on Pap smears with HPV testing in order to increase the yield of detecting SIL in postmenopausal women. In our study, we found that with respect to high-risk HPV testing in patients having both Pap smear and biopsies performed, we found the Pap smear diagnoses correlated better with positive high-risk HPV (sensitivity = 97.0 vs. 87.5% in the premenopausal and postmenopausal women, respectively) than the corresponding colposcopic biopsies (sensitivity = 62.0 vs. 37.5% in the premenopausal and postmenopausal women, respectively), whereas the PPVs were comparable between 2 groups (75.0 vs. 77.8%, respectively). Matthews-Greer et al. [20] found a 78% agreement between Pap smear findings and HPV testing results. Venturoli et al. [21] found a direct linear relationship between cytology diagnostic tiers and incidence of HPV positivity, increasing from 21% in samples with no abnormality to 76% in HSIL samples. HPV DNA is a valuable adjunct to the Pap smear as a screening tool. It seems plausible that women with SIL on Pap smear and positive HPV DNA but negative colposcopic biopsy are, due to errors during sampling, more likely to have a FN biopsy than a FP Pap smear.
Conclusion
Based on our findings, we concluded that there is a significant difference in cytohistologic correlation between premenopausal and postmenopausal women (PPV = 62 vs. 38%, respectively). Whether the lack of correlation was due to a FP Pap smear or FN biopsy will require further investigation, but many of the FP cases in postmenopausal women had an absent TZ (47%) on biopsy, and of those who underwent high-risk HPV testing performed, the majority were positive (83.3%). We suggest this indicates a potential sampling error on biopsy, perhaps due to an inability to visualize the involved area in older women because of an upward migration of the TZ.
